The new data – from the ARISE trial – found that Cobenfy wasn't statistically better than placebo at improving the widely ...

Oncology Clinical Trial Market Roche is actively conducting pivotal trials for novel therapies targeting advanced breast cancer, aiming to ...

After mid-day highlighted the issues posed by make-shift toilet blocks along Ram Mandir railway station road, WR removed all ...

Neurocrine Biosciences' valbenazine shows promise as an adjunctive therapy for Schizophrenia, with phase 3 data expected in ...

Cantor Fitzgerald initiated or transferred coverage on 10 large-cap U.S. biopharma stocks in a note Tuesday, highlighting a selective approach that favors dominant franchises with strong growth ...

Bristol-Myers Squibb (BMY) stock is down 11% year-to-date as the company navigates several looming patent cliffs. After a $13 ...

The following personnel items are from the April 9 agenda of the Bettendorf Community School District. The School Board met ...

"Dr. Mekan brings a combined 18 years of experience in hematology and oncology across academic research, clinical practice ...

U.K. regulators cleared a multiple myeloma drug GSK withdrew from market three years ago. Elsewhere, an investment firm pressed Elevation Oncology to liquidate and the FDA relaxed risk monitoring ...

Squibb announced that the U.S. Food and Drug Administration has updated the U.S. Prescribing Information for Camzyos, ...

A pill developed by GSK was found to be safe and effective in treating gonorrhea in a late-stage clinical trial. Novartis ...

With Trump's tariffs looming, is this really the appropriate time to load up on pharma stocks? And where does Cipla stand in ...